Related Experiment Video

Updated: Sep 25, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change

Dace L Trence1, Janet L Kelly, Irl B Hirsch

  • 1Division of Metabolism, Endocrinology, and Nutrition, University of Washington School of Medicine, Seattle, Washington 98195-6176, USA.

The Journal of Clinical Endocrinology and Metabolism
|June 6, 2003
PubMed

Insights

Aggressive glycemic control using intravenous glucose, insulin, and potassium (GIK) improves hospital patient outcomes, particularly for those with cardiovascular disease. Understanding insulin administration is crucial for effective treatment, even in non-diabetic patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Critical Care Medicine

Background:

  • Hyperglycemia is linked to poor wound healing and increased infections, especially post-cardiac surgery.
  • Aggressive glycemic control shows promise for improving clinical outcomes in hospitalized patients.
  • Cardiovascular disease patients may particularly benefit from optimized blood sugar management.

Purpose of the Study:

  • To review the evidence supporting aggressive glycemic control in hospitalized patients.
  • To explore the mechanisms behind improved outcomes with glucose, insulin, and potassium (GIK) therapy.
  • To emphasize the importance of understanding insulin administration for effective patient care.

Main Methods:

  • Review of existing literature on glycemic control strategies in hospitalized patients.
  • Analysis of studies investigating the effects of intravenous (i.v.) glucose, insulin, and potassium (GIK) administration.
  • Discussion of the practical aspects of both i.v. and subcutaneous (s.c.) insulin use.

Main Results:

  • Evidence suggests that aggressive glycemic control improves outcomes in hospitalized patients, including those without diabetes.
  • Intravenous GIK therapy has demonstrated better clinical outcomes.
  • Potential mechanisms include insulin's effect on cytokines and free fatty acids.

Conclusions:

  • Effective glycemic management, particularly with insulin, is vital for improving patient outcomes in hospital settings.
  • Caregivers must be knowledgeable about various insulin administration strategies (i.v. and s.c.).
  • Further research into the precise mechanisms of insulin's benefits is warranted.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...